STOCK TITAN
  1. Home
  2. News
  3. GDRX

GoodRx Holdings, Inc. - GDRX STOCK NEWS

Welcome to our dedicated page for GoodRx Holdings news (Ticker: GDRX), a resource for investors and traders seeking the latest updates and insights on GoodRx Holdings stock.

GoodRx Holdings, Inc. (Symbol: GDRX) is a leading consumer-focused digital healthcare platform committed to reducing the cost of healthcare in the United States. The company operates a price comparison platform that provides consumers with current, geographically relevant pricing for prescription medications. GoodRx gathers prices from multiple sources, offering powerful savings tips, valuable discounts, and negotiable price codes for prescriptions at virtually every pharmacy across the US.

GoodRx serves millions of Americans each month, including thousands of physicians who use the platform to help their patients. To date, the company has saved users over $3 billion on their prescription drug costs. Despite this success, GoodRx continues to work toward making prescriptions affordable for all Americans.

The company's core revenue stream comes from pharmacy benefit managers (PBMs), who manage formularies and prescription transactions. GoodRx also offers additional healthcare products and services such as pharma manufacturer solutions, subscription plans, and telehealth services. Their platform extends beyond individual consumers to include solutions for health plans, payors, and PBMs through an easy-to-use website and mobile app experience known as GoodRx for Benefits.

As GoodRx continues to innovate and expand its offerings, it remains dedicated to its mission of lowering healthcare costs and making essential medications accessible to everyone in the US. Stay updated with the latest news and developments from GoodRx to see how they are transforming the healthcare landscape.

News

GoodRx Appoints Kelly J. Kennedy to Board of Directors

Rhea-AI Summary
GoodRx (Nasdaq: GDRX) appoints Kelly J. Kennedy, former CFO of The Honest Company, to its Board of Directors, bringing over 25 years of experience in retail and consumer brands. Kennedy will serve on the audit committee, leveraging her expertise in risk assessment management and financial reporting. She currently serves as CFO for Willow Innovations and has previously held CFO positions at The Bartell Drug Company and The Honest Company.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.62%
Tags
management
-
News

GoodRx to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary
GoodRx Holdings, Inc. (Nasdaq: GDRX) executives will participate in a fireside chat at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024. The live webcast will be available on the Company's Investor Relations website, with an archived recording available for at least 30 days.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.62%
Tags
conferences
-
News

Amino Health Announces John Asalone as New CEO; David Vivero Assumes Role of Chairman in CEO Succession

Rhea-AI Summary
Amino Health (AMNO), a leading digital healthcare navigation company, announced the appointment of John Asalone as the new CEO, succeeding founder and former CEO David Vivero. Asalone, a seasoned executive with 20 years of experience scaling software and marketplace companies, aims to bring consumer-grade experiences to healthcare. Amino has secured $80 million in financing, paving the way for future growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.29%
Tags
management
News

Established Executive and Milwaukee Business Leader Jim Emling Joins VBA as Executive Chair of the Board of Directors

Rhea-AI Summary
Datassential's former CEO, Jim Emling, has been appointed Executive Chair of the Board of Directors at VBA, a company heavily investing in sales and product development after closing a growth equity transaction led by Spectrum Equity and Arthur Ventures. VBA serves the entire payer landscape, including third party administrators (TPAs) and health plans, with its next-gen Core Administrative Processing System, user engagement platforms, customer support tools, population health reporting solution, and robust data connections.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
management
-
News

GoodRx to Participate in the Evercore ISI HealthCONx Conference

Rhea-AI Summary
GoodRx Holdings, Inc. (Nasdaq: GDRX) executives will participate in a fireside chat at the Evercore ISI HealthCONx Conference in Miami, FL on November 30, 2023. The live webcast will be available on the Company's Investor Relations website, with an archived recording available for at least 30 days. This event aims to provide valuable insights into the company's position in the healthcare industry and its future prospects.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.58%
Tags
conferences
-
News

GoodRx Reports Third Quarter 2023 Results

Rhea-AI Summary
GDRX - GoodRx Holdings, Inc. Releases Q3 2023 Financial Results, Reports Revenue of $180.0M, Net Loss of $38.5M, and Over 550,000 Prescribers Engaged. Anticipates 4Q 2023 Revenue of $188-$194M and Adjusted EBITDA Margin in Mid-to-High Twenty-Percent Range
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-18.83%
Tags
earnings
News

GoodRx Announces New Way for Consumers to Access Sanofi’s Lantus for $35 at Over 70,000 Pharmacies Nationwide

Rhea-AI Summary
GoodRx partners with Sanofi to offer affordable access to Lantus insulin for people with diabetes
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.56%
Tags
none
-
News

GoodRx Announces Date for Third Quarter 2023 Earnings Release and Conference Call

Rhea-AI Summary
GoodRx Holdings, Inc. will release its Q3 2023 financial results on November 9, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.03%
Tags
earnings
-
News

GoodRx and Navitus Health Solutions Announce Savings Connect Program to Deliver Lower Prescription Prices for Navitus Members

Rhea-AI Summary
GoodRx and Navitus Health Solutions launch Savings Connect program for automatic access to GoodRx prices on generic drugs
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.88%
Tags
none
News

GoodRx Announces Significant Savings on Antivirals, Medications and Vaccines for Cold & Flu Season

Rhea-AI Summary
GoodRx offers new savings on antivirals, medications, and vaccines for the upcoming cold and flu season, potentially benefiting Americans by providing affordable ways to prevent or treat seasonal illnesses. They saved Americans over $20 million on cold and flu treatments last season. GoodRx is working with Walgreens, Walmart, and Weis to offer flat rates for flu shots, making them more accessible. They also provide savings on common flu treatments. GoodRx is helping Americans prepare for rising COVID-19 and RSV cases, providing expert advice on vaccines and offering resources from medical experts. GoodRx Health offers information and guides to navigate the 'tripledemic'.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.08%
Tags
none

FAQ

What is the current stock price of GoodRx Holdings (GDRX)?

The current stock price of GoodRx Holdings (GDRX) is $4.9 as of November 22, 2024.

What is the market cap of GoodRx Holdings (GDRX)?

The market cap of GoodRx Holdings (GDRX) is approximately 1.8B.

What does GoodRx Holdings, Inc. do?

GoodRx Holdings, Inc. is a digital healthcare platform that helps reduce the cost of prescriptions by offering price comparisons, discounts, and savings tips for medications across the US.

How does GoodRx save money on prescriptions?

GoodRx collects and compares current prescription prices from various sources, providing users with discounts and negotiable price codes that can be used at nearly every pharmacy in the US.

Who benefits from using GoodRx?

Millions of Americans, including those with insurance or Medicare, benefit from using GoodRx to find affordable prescription prices. Physicians also use GoodRx to help their patients save money.

How much has GoodRx saved Americans so far?

GoodRx has saved Americans over $3 billion on their prescription drug costs.

What additional services does GoodRx offer?

Besides price comparison and discounts, GoodRx offers pharma manufacturer solutions, subscription plans, telehealth services, and GoodRx for Benefits, which provides solutions for health plans, payors, and PBMs.

How does GoodRx generate revenue?

GoodRx generates revenue primarily from pharmacy benefit managers (PBMs) who manage formularies and prescription transactions. The company also earns from its additional healthcare products and services.

What is GoodRx for Benefits?

GoodRx for Benefits is a technology solution that provides health plans, payors, and PBMs with an easy-to-use website and mobile app experience to manage and reduce healthcare costs.

Is GoodRx available as a mobile app?

Yes, GoodRx offers a mobile app that allows users to compare prescription prices, find discounts, and access savings tips on the go.

Why should I use GoodRx if I already have insurance?

Even with insurance or Medicare, prescription costs can be high. GoodRx helps you find lower prices and better discounts, making medications more affordable.

Where can I learn more about GoodRx?

Visit www.goodrx.com to learn more about how GoodRx can help you save on prescriptions and explore their additional healthcare services.

Stock GDRX logo
GoodRx Holdings, Inc.

Nasdaq:GDRX

GDRX Rankings

#2101 Ranked by Market Cap
N/A Ranked by Dividends

GDRX Stock Data

1.75B
88.30M
11.9%
70.75%
2.28%
Health Information Services
Services-computer Processing & Data Preparation
Link
United States of America
SANTA MONICA